Novellia's GLP-1 Research Accepted for Poster Presentation at the 2026 American Public Health Association Annual Meeting and Expo

Novellia's research on GLP-1 therapies has been accepted as a poster presentation at the 2026 American Public Health Association (APHA) Annual Meeting and Expo. The meeting takes place November 1-4 in San Antonio, Texas.

GLP-1 therapies have become part of everyday care for many people, which makes real-world evidence on their use a valuable subject for public health research.

Health Across the Lifespan

The 2026 APHA theme is "Together We Thrive: Health Across the Lifespan." Health unfolds over years, across providers, and through every stage of life. Novellia's mission is to help every person reclaim ownership of their health, one medical record at a time by helping patients gather their complete health record from every system, practice, and provider they have seen going back over 20 years. The result is the most complete data story for both patients and life sciences researchers.

Research Centered on the Patient

Patients who use Novellia choose to consent to the use of their de-identified data for medical research, contributing evidence that can improve care for others. Researchers receive consented, de-identified, longitudinal records that reflect how patients experience care across providers and settings. With that view, research teams study treatment patterns and health trajectories in real-world practice across the same span of years that patients lived them.

Why the APHA Annual Meeting Matters

The APHA Annual Meeting and Expo is the largest public health gathering of the year, convening approximately 11,000 public health professionals and partners from around the world, including researchers, practitioners, students, government agencies, and advocates. Presenting at APHA gives Novellia a chance to share its belief that research centered and consented by the patient fills gaps often left behind by traditional datasets like claims or single-source EHR.

Frequently Asked Questions

What are GLP-1 therapies?

GLP-1 therapies are a class of medicines that act on the glucagon-like peptide-1 pathway, which helps regulate blood sugar and appetite. They are prescribed for conditions that include type 2 diabetes and chronic weight management.

What is APHA?

The American Public Health Association is a national organization for public health professionals. For more than 150 years, it has brought people together to improve the health of the American people.

What is the APHA Annual Meeting and Expo?

The APHA Annual Meeting and Expo offers oral scientific sessions, poster sessions, roundtables, lightning presentations, and a Public Health Expo. It is the flagship gathering of APHA.

When and where is the 2026 APHA Annual Meeting and Expo?

The 2026 meeting takes place November 1-4 at the Henry B. González Convention Center in San Antonio, Texas.

‍